Nurix Therapeutics, Inc. ( NRIX) - Key Metrics
NRIX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $6.03 | $4.93 | $5.52 | $5.51 |
| 2026Q2 | $0.08 | -$0.81 | -$0.87 | -$0.89 |
| 2026Q1 | $0.06 | -$0.79 | -$0.65 | -$0.66 |
| 2025Q4 | $0.14 | -$0.82 | -$0.71 | -$0.77 |
| 2025Q3 | $0.09 | -$1.03 | -$0.68 | -$0.71 |
NRIX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | 1.31 |
| 2026Q2 | 0% | -5.37 |
| 2026Q1 | 0% | -5.05 |
| 2025Q4 | 0% | -5.16 |
| 2025Q3 | 0% | -2.27 |
NRIX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 21.36% | 0% |
| 2026Q2 | -5.10% | 0% |
| 2026Q1 | -4.15% | 0% |
| 2025Q4 | -4.54% | 0% |
| 2025Q3 | -7.65% | 0% |
NRIX
Price: $26.80
52 week price:
Earnings Per Share: 2.43 USD
P/E Ratio: 10.05
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 161700
Market Capitalization: 2.7 billion